Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roby Reuven Zomer Insider Profile
4 Followers
Roby Reuven Zomer, Chief Executive Officer, Ten Percent Owner at Argent Biopharma, holds 5.29M shares in Argent Biopharma (Ticker: RGTLF), holds 17.44M shares in Graft Polymer (UK) PLC (Ticker: GB:GPL).
Roby Reuven Zomer Argent Biopharma (RGTLF)Chief Executive Officer, Ten Percent Owner
Argent Biopharma (RGTLF)
Chief Executive Officer, Ten Percent Owner
Ranked #93,707 out of 100,202 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-73.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Roby Reuven Zomer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Roby Reuven Zomer
Roby Reuven Zomer's Trading History
Argent Biopharma
Oct 15, 2024
Chief Executive Officer, Ten Percent Owner
Uninformative Buy
―
$629.79K
Graft Polymer (UK) PLC
Jan 08, 2024
Director, Ten Percent Owner
Informative Buy
66.67K
£37.49K
List of latest transactions for each holding click on a transaction to see Roby Reuven Zomer's performance on stock
You May Also Like
Roby Reuven Zomer insider profile FAQ
What is the percentage of profitable transactions made by Roby Reuven Zomer?
The percentage of profitable transactions made by Roby Reuven Zomer is 0%.
What is the average return per transaction made by Roby Reuven Zomer?
The average return per transaction made by Roby Reuven Zomer is -73.20%.
What stocks does Roby Reuven Zomer hold?
Roby Reuven Zomer holds: RGTLF, GB:GPL stocks.
What was Roby Reuven Zomer’s latest transaction?
Roby Reuven Zomer latest transaction was an Uninformative Buy of ―.
What was Roby Reuven Zomer's most profitable transaction?
Roby Reuven Zomer’s most profitable transaction was an Informative Buy of GB:GPL stock on January 8, 2024. The return on the trade was -66.90%.
What is Roby Reuven Zomer's role in Argent Biopharma?
Roby Reuven Zomer's role in Argent Biopharma is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.